AI
PMVP icon

Atom Investors’s PMV Pharmaceuticals PMVP Stock Holding History

Atom Investors’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,249
Closed -$99K – 621
2024
Q1 		$99K Buy
58,249
+17,184
+42% +$32.1K 0.01% 522
2023
Q4 		$127K Buy
+41,065
New +$109K 0.02% 415
2021
Q4 		– Sell
-27,199
Closed -$811K – 375
2021
Q3 		$811K Sell
27,199
-65,814
-71% -$2.1M 0.07% 154
2021
Q2 		$3.18M Buy
+93,013
New +$3.11M 0.4% 41

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Atom Investors's PMVP Position: Q2 2024 in Review

Atom Investors sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 58,249 shares — an estimated $99K sold.

Atom Investors first reported a position in PMVP in Q2 2021 and held it in 4 quarters. The position peaked at $3.18M in Q2 2021. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Atom Investors reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 58,249 PMV Pharmaceuticals shares in Q2 2024, an estimated $99K.
  • Atom Investors first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Atom Investors's PMV Pharmaceuticals position peaked at $3.18M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.